Dicembrini, Ilaria
Serni, Lapo
Monami, Matteo
Caliri, Mariasmeralda
Barbato, Luigi
Cairo, Francesco
Mannucci, Edoardo
Article History
Received: 9 March 2020
Accepted: 27 March 2020
First Online: 21 April 2020
Compliance with ethical standards
:
: Ilaria Dicembrini has received speaking fees from Merck, Novartis, Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Novo Nordisk, Sanofi and Novartis. Edoardo Mannucci has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi and Novartis and research grants from Merck, Novartis and Takeda. Matteo Monami has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi and Novartis and research grants from Bristol Myers Squibb. Francesco Cairo has received consultancy fees and grants from Straumann and Geistlich Biomaterials. Others authors have nothing to disclose.
: The meta-analysis was reported following the standard statements. All analyses were performed using comprehensive meta-analysis version 2, Biostat, (Englewood, NJ, USA) and SPSS 16.0.
: For this type of study consent is not required.